Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

POTP

Point Therapeutics (MM) (POTP)

Point Therapeutics (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:POTP
DateTimeSourceHeadlineSymbolCompany
05/15/200710:02AMBusiness WireCORRECTING and REPLACING Point Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta StuNASDAQ:POTPPoint Therapeutics (MM)
05/15/20078:01AMBusiness WirePoint Therapeutics Announces Interim Analysis to be Performed on Its Phase 3 Talabostat with Alimta StudyNASDAQ:POTPPoint Therapeutics (MM)
05/10/20078:00AMBusiness WirePoint Therapeutics Reports First Quarter 2007 Financial ResultsNASDAQ:POTPPoint Therapeutics (MM)
04/13/20078:00AMBusiness WirePoint Therapeutics Announces Preclinical Data Presentations at Upcoming American Association of Cancer Research Annual MeetingNASDAQ:POTPPoint Therapeutics (MM)
03/26/20078:24AMBusiness WirePoint Therapeutics Announces Management Change and Additional Information In Compliance With NASDAQ RulesNASDAQ:POTPPoint Therapeutics (MM)
03/16/20071:16PMBusiness WirePoint Therapeutics Reports Fourth Quarter and Year-End 2006 Financial ResultsNASDAQ:POTPPoint Therapeutics (MM)
03/13/20078:30AMBusiness WirePoint Therapeutics Receives Letter from Nasdaq Citing Non-Compliance with Minimum Bid Price RulesNASDAQ:POTPPoint Therapeutics (MM)
03/01/20077:25AMBusiness WirePoint Therapeutics Provides Clinical UpdateNASDAQ:POTPPoint Therapeutics (MM)
01/24/20078:12AMBusiness WirePoint Therapeutics Announces Resignation of William Whelan from Board of DirectorsNASDAQ:POTPPoint Therapeutics (MM)
01/12/20077:44AMBusiness WirePoint Therapeutics Provides Preliminary Results from Phase 2 Metastatic Pancreatic Cancer StudyNASDAQ:POTPPoint Therapeutics (MM)
11/09/20064:03PMBusiness WirePoint Therapeutics Reports Third Quarter 2006 Financial ResultsNASDAQ:POTPPoint Therapeutics (MM)
11/03/20067:30AMBusiness WirePoint Therapeutics to Present at Upcoming Conferences in New York CityNASDAQ:POTPPoint Therapeutics (MM)
11/02/20068:02AMBusiness WirePoint Therapeutics to Host Third Quarter 2006 Results Conference Call/Audio WebcastNASDAQ:POTPPoint Therapeutics (MM)
10/30/20067:50AMBusiness WireNew Data Demonstrates Talabostat's Anti-Tumor and Anti-Metastatic Properties in Preclinical Osteosarcoma ModelsNASDAQ:POTPPoint Therapeutics (MM)
09/18/20067:30AMBusiness WireTalabostat Phase 2 Non-Small Cell Lung Cancer Trial Featured at the 14th International Conference on Gene Therapy of CancerNASDAQ:POTPPoint Therapeutics (MM)
09/14/20067:49AMBusiness WireNew Data Supports Talabostat's Ability to Stimulate Key Cytokines Essential to Immunostimulation; Point Therapeutics, Inc. PreseNASDAQ:POTPPoint Therapeutics (MM)
08/14/20067:00AMBusiness WirePoint Therapeutics to Present at the New York RedChip Investor ConferenceNASDAQ:POTPPoint Therapeutics (MM)
08/08/20064:10PMBusiness WirePoint Therapeutics Reports Second Quarter 2006 Financial Results; Conference Call Scheduled for Today at 4:30 PM ETNASDAQ:POTPPoint Therapeutics (MM)
08/02/20068:23AMBusiness WirePoint Therapeutics to Host Second Quarter 2006 Results Conference Call/Audio WebcastNASDAQ:POTPPoint Therapeutics (MM)
06/27/20069:10AMBusiness WirePoint Therapeutics' Diabetes Program Presented at the Endocrine Society Annual MeetingNASDAQ:POTPPoint Therapeutics (MM)
06/13/20067:50AMBusiness WirePoint Therapeutics Announces Annual Meeting of Stockholders on June 20, 2006 in Boston; Meeting will be Web CastNASDAQ:POTPPoint Therapeutics (MM)
06/12/20068:10AMBusiness WirePoint Therapeutics' Diabetes Program Presented at American Diabetes Association 66th Annual Scientific Sessions; Chronic AdminiNASDAQ:POTPPoint Therapeutics (MM)
06/08/20067:00AMBusiness WirePoint Therapeutics Summarizes New Data Evaluating Its Lead Compound, Talabostat, in Four Distinct Cancers at the 2006 AmericanNASDAQ:POTPPoint Therapeutics (MM)
06/07/20068:22AMBusiness WirePoint Therapeutics to Present at the Pacific Growth Equities Life Sciences Growth ConferenceNASDAQ:POTPPoint Therapeutics (MM)
06/01/20067:00AMBusiness WirePoint Therapeutics Receives Fast Track Designation for TalabostatNASDAQ:POTPPoint Therapeutics (MM)
05/31/20067:53AMBusiness WirePoint Therapeutics Announces New Data Evaluating Its Lead Compound, Talabostat, in Four Distinct CancersNASDAQ:POTPPoint Therapeutics (MM)
05/30/20067:44AMBusiness WirePoint Therapeutics to Present at Friedman Billings Ramsey 2006 Growth Investor ConferenceNASDAQ:POTPPoint Therapeutics (MM)
05/09/20064:01PMBusiness WirePoint Therapeutics Reports First Quarter 2006 Financial Results; Conference Call Scheduled for May 9, 2006 at 4:30 PM ESTNASDAQ:POTPPoint Therapeutics (MM)
05/09/20067:30AMBusiness WirePoint Therapeutics to Present at Rodman & Renshaw 3rd Annual Global Healthcare ConferenceNASDAQ:POTPPoint Therapeutics (MM)
05/04/20067:30AMBusiness WirePoint Therapeutics to Host First Quarter 2006 Results Conference Call/Audio WebcastNASDAQ:POTPPoint Therapeutics (MM)
 Showing the most relevant articles for your search:NASDAQ:POTP